CellaVision AB (CellaVision AB) Long-Term Debt : $2.45 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is CellaVision AB Long-Term Debt?

CellaVision AB's Long-Term Debt for the quarter that ended in Mar. 2024 was $2.45 Mil.

CellaVision AB's quarterly Long-Term Debt declined from Sep. 2023 ($2.95 Mil) to Dec. 2023 ($2.79 Mil) and declined from Dec. 2023 ($2.79 Mil) to Mar. 2024 ($2.45 Mil).

CellaVision AB's annual Long-Term Debt declined from Dec. 2021 ($10.54 Mil) to Dec. 2022 ($5.82 Mil) and declined from Dec. 2022 ($5.82 Mil) to Dec. 2023 ($2.79 Mil).

CellaVision AB Long-Term Debt Historical Data

The historical data trend for CellaVision AB's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CellaVision AB Long-Term Debt Chart

CellaVision AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

10.54

5.82

2.79

CellaVision AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Debt	Get a 7-Day Free Trial															5.04	4.01	2.95	2.79	2.45

CellaVision AB (OTCPK:CLVSF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

CellaVision AB Long-Term Debt Related Terms

Thank you for viewing the detailed overview of CellaVision AB's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CellaVision AB (CellaVision AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CellaVision AB (OTCPK:CLVSF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

CEVI:Sweden 0MR5:UK C26:Germany

Address

Mobilvagen 12, Lund, SWE, 22362

Website

https://www.cellavision.com

CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

CellaVision AB (CellaVision AB) Headlines

From GuruFocus

3 Scandinavian Companies With Strong Margin Growth

By James Li James Li • 12-01-2020